Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1388 | Thyroid (non-cancer) | ECE2017

Neuroendocrine progression of medullary thyroid cancer – case report

Sepp Krisztian , Besenyi Zsuzsanna , Tiszlavicz Laszlo , Valkusz Zsuzsanna

: Thyroid cancers represent approximately 1% of new cancer diagnoses. Thyroid malignancies are divided into papillary carcinomas (80%), follicular carcinomas (10%), medullary carcinomas (5–10%), anaplastic carcinomas (1–2%) other rare tumours (primary thyroid lymphomas, primary thyroid sarcomas). The main therapeutic options are surgery (mainly total thyreoidectomy), radioiodine treatment (depending on the type and stage of the tumour), levothyroxine therapy (thyroid...